# CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
> **ANDA211421** · Abbreviated New Drug Application (Generic) · Sponsor: NUVO PHARMS INC · Approved 2020-07-07
## Drug
- **FDA Application Number:** ANDA211421
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
- **Generic name:** CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
- **Active ingredients:** CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NUVO PHARMS INC
- **Manufacturer:** Sunrise Pharmaceutical, Inc.
- **First approval:** 2020-07-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211421)
---
*AI Analytics · CC0 1.0*